Paroxysmal nocturnal hemoglobinuria is a rare blood disorder that can cause severe tiredness, dark urine, shortness of breath, belly pain, and blood clots. The early symptoms of paroxysmal nocturnal hemoglobinuria can be easy to miss, and some people are diagnosed only after anemia or an unusual clot is found. It usually starts in adults, but it can happen at other ages, and it often lasts for years without treatment. Not everyone will have the same experience. Paroxysmal nocturnal hemoglobinuria can be life-threatening because of clotting and bone marrow failure, but treatment such as complement-blocking medicines, blood transfusions, and sometimes stem cell transplant can greatly improve outcomes.
How many people live with Paroxysmal nocturnal hemoglobinuria?
Worldwide, paroxysmal nocturnal hemoglobinuria is estimated to affect about 8,000 to 73,000 people, based on Orphanet’s range of roughly 1 to 9 people per 1 million and the fact that estimates vary depending on how cases are found and diagnosed (Orphanet, 2024). Using that same range, about 340 to 3,100 people in the United States may be living with it, so this is also an estimate rather than a direct count (Orphanet, 2024).
Overview
Paroxysmal nocturnal hemoglobinuriaSymptoms
Paroxysmal nocturnal hemoglobinuria can cause severe tiredness, shortness of breath, dark or red-brown urine, and headaches. Many with paroxysmal nocturnal hemoglobinuria also bruise or bleed easily. Early symptoms of paroxysmal nocturnal hemoglobinuria can include belly pain or blood clots.
Outlook and prognosis
With paroxysmal nocturnal hemoglobinuria, outlook has improved greatly: many people live for years with treatment that lowers blood clot risk and controls red blood cell breakdown. Prognosis varies, especially if bone marrow failure is also present.
Causes and risk factors
Paroxysmal nocturnal hemoglobinuria usually starts from an acquired PIGA gene change in bone marrow stem cells. It is not inherited. Risk is higher with aplastic anemia or related marrow disorders; lifestyle and environmental risks are unclear.
Genetic influences
Genetics are central to paroxysmal nocturnal hemoglobinuria, but it is usually not inherited. It most often happens because a blood-forming stem cell acquires a PIGA gene change during life, and different acquired variants can affect how severe paroxysmal nocturnal hemoglobinuria becomes.
Diagnosis
Diagnosis of Paroxysmal nocturnal hemoglobinuria usually starts with blood tests showing anemia or ongoing red blood cell breakdown. Doctors confirm Paroxysmal nocturnal hemoglobinuria with flow cytometry, a blood test that looks for missing protective proteins on blood cells.
Treatment and drugs
Treatment for paroxysmal nocturnal hemoglobinuria often centers on medicines that calm the overactive immune attack on blood cells, such as complement blockers. Some people also need blood transfusions, iron or folate, blood thinners, or a stem cell transplant.
Symptoms
Paroxysmal nocturnal hemoglobinuria can make everyday life feel draining, with low energy, breathlessness, or urine that looks tea-colored, especially in the morning. In this condition, red blood cells break down too easily, which can lead to anemia and symptoms in several parts of the body. You might notice small changes at first, and the early symptoms of Paroxysmal nocturnal hemoglobinuria are often easy to mistake for stress, poor sleep, or just feeling run-down. Some people mainly have fatigue, while others develop pain, blood clots, or problems linked to low blood counts.
Many people feel unusually tired, weak, or lightheaded because the blood is not carrying oxygen as well as it should. Even simple tasks like climbing stairs or getting through a workday can feel harder than usual.
Urine may look red, brown, or tea-colored when broken-down blood pigments pass into it, often after waking up. In Paroxysmal nocturnal hemoglobinuria, this can come and go rather than happen every day.
Low red blood cell levels can leave you short of breath, dizzy, or aware of a fast heartbeat, especially with activity. Some people also notice chest discomfort or that exercise feels much harder than before.
Belly pain, back pain, chest pain, or trouble swallowing can happen when this condition affects blood flow and muscle tone. Some men also notice erectile problems during symptom flares.
How people usually first notice Paroxysmal nocturnal hemoglobinuria?
Many people first notice paroxysmal nocturnal hemoglobinuria when fatigue starts to feel out of proportion to daily life, or when shortness of breath, headaches, or a racing heartbeat show up because the body is struggling with anemia, which means too few healthy red blood cells. Some living with PNH also notice dark brown, red, or tea-colored urine, often more obvious in the morning, because damaged red blood cells are breaking apart and releasing hemoglobin into the urine. In others, the first clue is less specific, such as unusual belly pain, trouble swallowing, back pain, erectile dysfunction, or a blood clot in an unexpected place, which is why how paroxysmal nocturnal hemoglobinuria is first noticed can vary quite a bit from person to person.
Types of Paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria can affect daily life in different ways, from dark urine and deep fatigue to blood clots or low blood counts found on testing. Symptoms don’t always look the same for everyone. In practice, doctors often describe a few main types of paroxysmal nocturnal hemoglobinuria based on how much red blood cell breakdown is happening and whether bone marrow failure is also present.
Classic PNH
This type is marked by ongoing breakdown of red blood cells, which can cause dark urine, tiredness, shortness of breath, belly pain, or trouble swallowing. People with classic paroxysmal nocturnal hemoglobinuria also have a higher risk of blood clots, sometimes in unusual places such as veins in the abdomen or brain.
PNH with marrow failure
In this type, paroxysmal nocturnal hemoglobinuria occurs along with bone marrow problems such as aplastic anemia, so the body may not make enough blood cells. Many living with this form have symptoms from low counts, like fatigue, frequent infections, or easy bruising and bleeding, while signs of red blood cell breakdown may be milder.
Subclinical PNH
This form means a small PNH cell population is present on blood testing, but there are few or no clear symptoms directly caused by PNH itself. It is often found in people being checked for another bone marrow disorder, and having one type doesn’t necessarily mean you’ll develop the others.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes can meaningfully delay the onset of paroxysmal nocturnal hemoglobinuria, because it is a rare blood disorder that starts from changes in blood-making cells, not from habits like diet, exercise, or sleep. Healthy routines still support overall health, but they have not been shown to prevent PNH or push symptoms back; if PNH is diagnosed, regular care with a blood specialist and medicines that calm the part of the immune system driving red blood cell damage can lower serious problems, but these treatments manage the condition rather than prevent it from starting. Research is ongoing, and while there is no proven way to stop PNH before it begins, getting checked early for signs like unusual tiredness, dark urine, or unexplained blood clots can help people get the right care sooner.
What genetics can tell you about symptoms
In paroxysmal nocturnal hemoglobinuria, genetics can help explain symptoms, but in a different way than in most inherited conditions: the disease usually starts from an acquired change in a blood-forming stem cell, not a gene change passed down in families. The size of the affected blood cell group can influence what shows up and how severe it is, so many people with a larger affected cell population are more likely to have ongoing breakdown of red blood cells, dark urine, fatigue, shortness of breath, belly pain, or blood clots, while others have milder symptoms or more signs of bone marrow failure. Genetics does not usually predict an exact age of onset or a fixed symptom pattern, because symptoms can vary widely from one person to another.
Causes and risk factors
Paroxysmal nocturnal hemoglobinuria usually starts when a blood-forming stem cell in the bone marrow picks up a change in a gene called PIGA. This gene change is acquired during life, not inherited, so paroxysmal nocturnal hemoglobinuria is not usually passed down in families. Many people with paroxysmal nocturnal hemoglobinuria also have bone marrow failure, especially aplastic anemia, and this can raise the chance that the changed cell will expand. That said, risk is only part of the story. No clear lifestyle or environmental cause has been proven for paroxysmal nocturnal hemoglobinuria, so things like diet, exercise, or everyday exposures are not known to directly cause it.
What are the most common causes or risk factors?
Paroxysmal nocturnal hemoglobinuria usually happens because of a change that develops later in life in a blood-forming stem cell in the bone marrow, so it is generally not inherited from a parent. The strongest known risk factor is having bone marrow failure problems, especially aplastic anemia, and less often certain related blood disorders. There are no well-proven lifestyle or environmental risk factors, and many people who develop it have no clear outside cause.
Environmental and biological risk factors
Paroxysmal nocturnal hemoglobinuria, or PNH, is rare, and its risk factors are mostly tied to what is happening inside the bone marrow rather than to everyday exposures. Researchers are still exploring how outside influences interact with our inner biology. For most people, the clearest risk factors for paroxysmal nocturnal hemoglobinuria are biological, especially disorders that injure or stress blood-forming stem cells.
Aplastic anemia is the strongest known risk factor for PNH. When the bone marrow is under immune attack and makes too few blood cells, a PNH cell group may be more likely to expand.
Some other bone marrow failure conditions, including certain myelodysplastic syndromes, can also be linked with paroxysmal nocturnal hemoglobinuria. These disorders change the marrow environment in ways that can favor abnormal blood-forming cells.
Immune damage inside the bone marrow appears to play a key biological role in many people with PNH. If healthy stem cells are being suppressed, a small abnormal cell group may gain a survival advantage.
PNH is often diagnosed in teenagers and younger to middle-aged adults, although it can happen at any age. Age does not directly cause the disorder, but it affects when this pattern is most often recognized.
Genetic risk factors
For many living with paroxysmal nocturnal hemoglobinuria, the problem starts in the bone marrow when one blood-forming stem cell picks up a change in a gene called PIGA. This is the main explanation for the genetic causes of paroxysmal nocturnal hemoglobinuria, and it usually happens during life rather than being inherited at birth. The change prevents blood cells from making a surface anchor that holds several protective proteins in place. As a result, red blood cells become much easier for the body to break apart.
PIGA gene: Most paroxysmal nocturnal hemoglobinuria begins with an acquired change in the PIGA gene in a single blood-forming stem cell. That changed cell can then produce many blood cells carrying the same defect.
Surface anchor: The PIGA change blocks production of a small anchor that normally attaches protective proteins to the surface of blood cells. Without that anchor, important proteins such as CD55 and CD59 cannot stay in place.
Not inherited: Unlike many genetic conditions, paroxysmal nocturnal hemoglobinuria is usually not passed down from a parent. Most people with PNH have no family history, and their children are not expected to inherit the disease from this acquired change.
Clone size: PNH is more likely to cause illness when the altered stem cell grows into a larger clone in the bone marrow. A small clone may cause little or no trouble, while a larger one is more likely to lead to early symptoms of paroxysmal nocturnal hemoglobinuria.
Rare other genes: Very rarely, changes in other genes involved in the same surface-anchor pathway can cause a similar pattern of disease. For most people with PNH, though, PIGA is the key gene involved.
Lifestyle risk factors
Paroxysmal nocturnal hemoglobinuria is not caused by lifestyle habits, but daily choices can still influence symptoms and complications. The main concern is that some habits may raise the risk of blood clots, worsen fatigue, or make anemia and kidney strain harder to manage. When people ask how lifestyle affects paroxysmal nocturnal hemoglobinuria, the most important issues are hydration, smoking, activity level, and overall strain on the body.
Smoking can increase blood vessel injury and make the already high clotting risk in paroxysmal nocturnal hemoglobinuria more dangerous. Avoiding tobacco may help lower the chance of thrombosis and cardiovascular complications.
Not drinking enough fluids can thicken the blood and may increase clot risk in people with paroxysmal nocturnal hemoglobinuria. Dehydration can also worsen fatigue, headaches, and kidney stress, especially during hot weather, vomiting, or diarrhea.
Sitting still for long periods, including during travel or bed rest, can further raise the risk of dangerous blood clots. Regular movement, leg exercises, and planned breaks are especially important in a condition already linked to thrombosis.
Very intense exercise can worsen shortness of breath, chest discomfort, or exhaustion when anemia is active. Gentle to moderate activity, adjusted to symptoms and blood counts, may help maintain stamina without overloading the body.
Risk prevention
For paroxysmal nocturnal hemoglobinuria, there is no known way to fully prevent the condition itself because it usually develops from a random change in blood-forming stem cells, not from something you did or did not do. Prevention for PNH mainly means lowering the risk of complications such as blood clots, severe anemia, kidney strain, and infections. Many living with PNH find that prevention is less about one big fix and more about steady medical care plus daily habits that reduce stress on the body. Prevention works best when combined with regular check-ups.
Regular follow-up with a blood specialist helps catch changes early and adjust treatment before problems build up. This can lower the risk of serious complications from PNH, especially blood clots and worsening anemia.
Blood clots are one of the most serious risks in PNH, so your doctor may recommend medicines to lower this risk if needed. Quick attention to new leg swelling, chest pain, severe headache, or shortness of breath can help prevent blood clots in paroxysmal nocturnal hemoglobinuria from becoming life-threatening.
Medicines that block the harmful part of the immune system can reduce red blood cell breakdown and help prevent complications. For many people with PNH, staying on treatment as prescribed is one of the most effective protective steps.
Some PNH treatments can raise the risk of certain infections, so vaccines and a clear plan for fever or sudden illness are important. Handwashing, avoiding close contact with people who are acutely sick, and getting urgent advice for high fever can also help.
Can you prevent Paroxysmal nocturnal hemoglobinuria?
No, in most cases you cannot prevent paroxysmal nocturnal hemoglobinuria, a rare blood condition that usually starts because of a random change in the blood-making cells in the bone marrow, not because of anything you did. There are no proven lifestyle changes that can stop it from developing. If you are living with it, regular medical care can help lower the risk of serious problems such as blood clots.
Transmission
Paroxysmal nocturnal hemoglobinuria is not infectious, so it cannot be passed from one person to another through touch, coughing, sex, sharing food, or day-to-day contact. It also is not usually a condition that runs in families.
People often ask about how Paroxysmal nocturnal hemoglobinuria is inherited, but in most cases it begins from a new change that develops during life in certain bone marrow cells, rather than a change passed down from a parent. For many living with Paroxysmal nocturnal hemoglobinuria, this means the condition is acquired, not contagious, and not something they are likely to pass on to their children.
When to test your genes
Paroxysmal nocturnal hemoglobinuria is usually not an inherited condition, so routine gene testing is not used for early detection. Testing is usually considered when people have unexplained blood clots, dark urine, anemia, or low blood counts; the key test is flow cytometry, not a hereditary gene panel.
Diagnosis
Paroxysmal nocturnal hemoglobinuria, or PNH, is usually diagnosed after blood problems show up over time, such as unexplained anemia, dark urine, blood clots, or ongoing fatigue. Many living with PNH first seek care because everyday tasks like climbing stairs or getting through a workday start feeling harder. Doctors usually begin with blood tests, because the diagnosis of paroxysmal nocturnal hemoglobinuria depends on showing that red blood cells are being damaged and confirming the cause.
A complete blood count looks for anemia and may also show low white blood cells or platelets. These results can suggest a bone marrow problem and help explain symptoms such as tiredness, shortness of breath, or easy bruising.
Blood tests measure signs that red blood cells are breaking apart too early, including high lactate dehydrogenase, high bilirubin, and low haptoglobin. These findings support PNH when symptoms or other test results point in that direction.
Urine tests may show hemoglobin, the red blood cell protein, especially during episodes of dark or reddish-brown urine. This can be a clue that blood cells are breaking down in the bloodstream rather than only inside the bone marrow.
This is the main test used to confirm PNH. It checks blood cells for missing protective surface proteins, which is the key abnormality in paroxysmal nocturnal hemoglobinuria.
How is Paroxysmal nocturnal hemoglobinuria diagnosed?
Doctors usually diagnose paroxysmal nocturnal hemoglobinuria, or PNH, with blood tests. Regular blood tests may show signs that red blood cells are breaking down too early and can also check for anemia or low blood cell counts, but the main test is a specialized blood test called flow cytometry, which looks for blood cells that are missing protective proteins on their surface. Some people also need a bone marrow test if their blood counts are low or if doctors are checking for another blood or marrow condition, while genetic testing is not usually needed to make the diagnosis.
Stages of Paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria does not have defined progression stages. This is because it usually does not move through a clear step-by-step pattern over time; instead, symptoms and complications can vary from person to person and may flare or worsen unpredictably. Doctors usually start with a conversation about symptoms such as fatigue, dark urine, shortness of breath, blood clots, or other early symptoms of paroxysmal nocturnal hemoglobinuria, then confirm the diagnosis with blood tests that look for missing protective proteins on blood cells. Ongoing monitoring usually involves regular blood counts and checks for signs of anemia, clotting, kidney strain, and breakdown of red blood cells.
Outlook and prognosis
Outlook in paroxysmal nocturnal hemoglobinuria has improved markedly, especially with complement inhibitors such as eculizumab, ravulizumab, and newer proximal complement therapies, which can reduce hemolysis, thrombosis, transfusion needs, and organ damage. Prognosis varies widely depending on disease severity, the presence of bone marrow failure, and whether life-threatening complications such as thrombosis occur. Before modern treatment, thrombosis was a leading cause of death and overall survival was substantially shortened, but many treated patients now have near-normal or clearly prolonged life expectancy. Mortality risk remains higher in people with severe thrombosis, serious infections, kidney or pulmonary complications, or progression to aplastic anemia or myelodysplastic syndromes. Some patients continue to have breakthrough hemolysis, fatigue, or transfusion dependence despite therapy, so long-term monitoring is important. For those who undergo successful stem cell transplantation, cure is possible, but the procedure carries significant short-term risks and is generally reserved for selected severe cases.
Long-term effects
For many living with paroxysmal nocturnal hemoglobinuria, the long-term picture depends on how much ongoing blood cell breakdown, clotting, and bone marrow problems are present. Some people have long stretches with milder day-to-day effects, while others develop serious complications that affect energy, organ health, and life expectancy. Long-term effects vary widely, and they can change over time as the condition evolves.
Ongoing anemia can leave people with paroxysmal nocturnal hemoglobinuria feeling drained, short of breath, or less able to manage ordinary tasks. Even a short walk, climbing stairs, or getting through a workday may take more effort than expected.
One of the most serious long-term effects of paroxysmal nocturnal hemoglobinuria is an increased risk of blood clots. These can affect veins in the abdomen, legs, lungs, or brain and may cause lasting organ damage or become life-threatening.
Repeated release of hemoglobin into the bloodstream can strain the kidneys over time. Some people develop chronic kidney disease, which may show up as falling kidney function, swelling, or changes in urine.
Many living with paroxysmal nocturnal hemoglobinuria also have reduced bone marrow function, which means the body may struggle to make enough blood cells. This can lead to ongoing anemia, more infections from low white blood cells, and easier bruising or bleeding from low platelets.
How is it to live with Paroxysmal nocturnal hemoglobinuria?
Living with paroxysmal nocturnal hemoglobinuria can feel unpredictable, because symptoms often come in waves rather than staying the same from day to day. Many people with PNH live with deep fatigue, shortness of breath, pain, headaches, or episodes of dark urine, and the risk of blood clots can make daily life feel more medically complicated, with frequent blood tests, treatments, and close follow-up shaping work, school, travel, and family plans. Those around you may also feel the impact, not because the condition is contagious, but because loved ones often help with appointments, watch for warning signs, and adapt to periods when energy is low.
Treatment and drugs
Paroxysmal nocturnal hemoglobinuria is usually treated by reducing the immune attack that damages red blood cells, preventing blood clots, and managing complications such as anemia, fatigue, or kidney strain. The main medicines are targeted drugs that block part of the immune system called complement, which can lower red blood cell breakdown and often improve day-to-day symptoms. Some people with paroxysmal nocturnal hemoglobinuria also need supportive treatment, such as blood transfusions, iron or folate, blood thinners to reduce clot risk, or antibiotics and vaccines if infection risk is a concern. Not every treatment works the same way for every person, and the plan may also depend on whether someone has related bone marrow failure, which can require medicines to support blood cell production or, in selected cases, a stem cell transplant. For many people, treatment begins with small daily steps, like keeping follow-up visits, tracking early symptoms of paroxysmal nocturnal hemoglobinuria, and talking with a specialist about which option best fits their risks and goals.
Can you cure Paroxysmal nocturnal hemoglobinuria?
Paroxysmal nocturnal hemoglobinuria can sometimes be cured with a bone marrow, or stem cell, transplant, but this is a serious treatment with real risks, so it is not the right choice for most people. For many living with this condition, treatment is aimed at controlling the disease rather than curing it, with medicines that help protect red blood cells, lower the risk of dangerous blood clots, and improve day-to-day symptoms like tiredness, shortness of breath, and dark urine.
Non-drug treatment
Living with paroxysmal nocturnal hemoglobinuria can mean planning around fatigue, dark urine, shortness of breath, or sudden symptoms that need urgent care. Managing this condition often includes supportive care that helps with daily symptoms, watches for complications, and, in some cases, aims for a long-term cure. Non-drug treatments are usually chosen based on how severe the blood cell breakdown is, whether bone marrow failure is also present, and whether serious problems like blood clots have occurred.
Red blood cell transfusions can help when anemia causes major fatigue, dizziness, or breathlessness with everyday tasks like climbing stairs. Platelet transfusions may also be used if low platelets raise the risk of bleeding.
A stem cell transplant replaces the diseased bone marrow with healthy donor cells and is the only treatment that can potentially cure PNH. Because it carries major risks, it is usually reserved for selected people with severe disease, especially when bone marrow failure is part of the picture.
Frequent blood tests help track anemia, blood cell counts, kidney function, and signs that PNH is becoming more active. This kind of follow-up is a key part of supportive care for paroxysmal nocturnal hemoglobinuria because problems can build gradually before they are obvious day to day.
Blood clots are one of the most serious complications of PNH, so reducing long periods of immobility and staying well hydrated can be part of everyday care. During travel, illness, surgery, or recovery in bed, the medical team may also suggest extra non-drug steps to lower risk.
Your genes may have an impact on how drugs work for you
For people with paroxysmal nocturnal hemoglobinuria, or PNH, inherited differences in the body can sometimes affect how well certain newer medicines control the immune attack that breaks down red blood cells. A well-known example is that a rare inherited change can make one of these targeted treatments work poorly in some people, so if someone is still needing transfusions or keeps having symptoms like dark urine, severe tiredness, or belly pain, the care team may look for that reason and consider a different treatment. Even so, for most people with PNH, day-to-day treatment choices are guided more by how active the disease is and how the body is responding than by routine genetic drug testing, a field called pharmacogenomics.
Pharmacological treatments
Paroxysmal nocturnal hemoglobinuria is often treated with medicines that calm the part of the immune system driving red blood cell breakdown, which can ease fatigue, dark urine, anemia, and clot risk. The main drugs today are complement inhibitors, and the choice depends on symptoms, blood counts, access, and whether treatment needs to be given by infusion, injection, or by mouth. Not everyone responds to the same medication in the same way. Some people also need medicines that treat complications or an overlap with bone marrow failure.
Eculizumab blocks complement protein C5 and has long been a standard treatment for PNH. It can reduce red blood cell destruction, lower the risk of dangerous blood clots, and improve quality of life.
Ravulizumab works in a similar way to eculizumab by blocking C5, but it lasts longer in the body. For many, this can mean less frequent infusions while still controlling hemolysis and lowering clot risk.
Crovalimab is another C5 blocker used for some people living with PNH. It aims to control ongoing hemolysis with a different dosing approach, which may be helpful when choosing among newer drugs for paroxysmal nocturnal hemoglobinuria.
Pegcetacoplan blocks complement earlier in the pathway at C3, so it may help when anemia continues despite C5 treatment. It can reduce both inside-the-blood-vessel and outside-the-blood-vessel red cell breakdown in some people with PNH.
Genetic influences
Many people ask whether paroxysmal nocturnal hemoglobinuria is hereditary. In paroxysmal nocturnal hemoglobinuria, a change in a gene (mutation or variant) can sometimes affect health, but the important point is that this change usually happens after birth in a blood-forming stem cell, most often in a gene called PIGA. That means this condition is usually acquired, not something parents pass to their children.
The altered cell line then makes blood cells that lack protective surface proteins, so the body’s complement system can break them down more easily. Many living with paroxysmal nocturnal hemoglobinuria also have bone marrow failure, such as aplastic anemia, which may help these changed cells grow, but close relatives are not typically at higher risk.
Is Paroxysmal nocturnal hemoglobinuria genetic?
Genetics are central to paroxysmal nocturnal hemoglobinuria, but it is usually not inherited. It most often happens because a blood-forming stem cell acquires a PIGA gene change during life, and different acquired variants can affect how severe paroxysmal nocturnal hemoglobinuria becomes.
Having a genetic risk is not necessarily a diagnosis
Genetic changes are a normal part of human biology and are widely found in the general population. Most of these variants do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, one well-understood variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with paroxysmal nocturnal hemoglobinuria, the key gene change helps explain why doctors often choose medicines that block complement, a part of the immune system that can damage red blood cells. If you are wondering how genetics affect treatment for paroxysmal nocturnal hemoglobinuria, the main point is that it usually begins with an acquired change in a bone marrow stem cell, not a gene variant you were born with. That change makes blood cells lose some of their usual protective surface proteins, so drugs such as eculizumab, ravulizumab, and pegcetacoplan can reduce red blood cell breakdown and lower the risk of serious problems like blood clots. Not every difference in response is genetic, but in paroxysmal nocturnal hemoglobinuria, routine pharmacogenetic testing is not usually used to choose these medicines. Instead, treatment is tailored more by how active the disease is, whether anemia or clotting has occurred, and whether there is overlap with bone marrow failure such as aplastic anemia. In other words, the genetics of paroxysmal nocturnal hemoglobinuria mainly guide treatment by showing which pathway to target, rather than by predicting your exact dose in the way some other medicines do.
Interactions with other conditions
For many living with paroxysmal nocturnal hemoglobinuria, or PNH, other health problems can change how the illness feels day to day and how urgently it needs treatment. The biggest concern is often blood clots, which can happen more easily in PNH and may affect the legs, lungs, abdomen, or even the brain, especially if someone already has other clotting risks. PNH can also overlap with bone marrow disorders such as aplastic anemia or myelodysplastic syndromes, so low blood counts may come from more than one process at the same time. Doctors call it a comorbidity when two conditions occur together. Infections can sometimes worsen PNH symptoms by triggering more red blood cell breakdown, which may lead to darker urine, more fatigue, shortness of breath, or worsening anemia. Kidney strain can also develop over time in some people with PNH because repeated breakdown of red blood cells can affect how well the kidneys filter the blood, so regular follow-up helps doctors watch for these interactions early.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Paroxysmal nocturnal hemoglobinuria?
Conditions that can look like paroxysmal nocturnal hemoglobinuria include other causes of red blood cell breakdown, such as autoimmune hemolytic anemia, sickle cell disease, or G6PD deficiency, as well as bone marrow problems like aplastic anemia or myelodysplastic syndrome, where the marrow does not make blood cells well. Dark or reddish urine can also be caused by blood in the urine from kidney stones, infections, or bladder problems, and unusual blood clots may happen with other clotting disorders too.
History
People living with paroxysmal nocturnal hemoglobinuria, or PNH, often spend years looking for an explanation for symptoms that seem to come and go, such as dark urine, unusual fatigue, belly pain, or blood clots. That uncertainty was part of the story for doctors, too. For a long time, this condition was recognized only by the pattern it left behind in daily life and on basic lab testing, not by a clear understanding of what was causing it.
In the late 1800s and early 1900s, physicians began publishing detailed case reports about people who had episodes of red or brown urine, especially after sleep, along with signs that red blood cells were breaking down inside the bloodstream. Early reports called it “nighttime blood breakdown in the urine,” reflecting what doctors noticed most clearly at the time, even though we now know the process is not limited to the night. As medical science evolved, doctors learned that the main problem was not bleeding into the urine from the kidneys or bladder, but damage to blood cells within the circulation.
By the mid-20th century, better blood tests helped separate PNH from other causes of anemia and dark urine. Researchers discovered that people with paroxysmal nocturnal hemoglobinuria can also have low blood counts and a higher risk of dangerous clots, which explained why the illness could affect much more than urine color alone. This changed how doctors thought about the condition: not as a narrow urine problem, but as a disorder that can involve the blood, bone marrow, and blood vessels.
Later, laboratory research showed that blood cells in PNH are unusually vulnerable to part of the immune system called complement, which normally helps the body fight infection. That insight opened the door to more accurate diagnosis and, eventually, targeted treatment. In recent decades, awareness has grown that early symptoms of paroxysmal nocturnal hemoglobinuria can be easy to miss, especially when fatigue or anemia seems to have a more common cause. Today, the history of PNH helps explain why diagnosis still sometimes takes time, but it also shows how far care has come, from describing a puzzling pattern of symptoms to treating the underlying process much more effectively.